医药行业分析
- (2025-09-05)
- (2025-09-05)
- (2025-09-05)
- (2025-09-05)
《新英格兰医学杂志》与欧洲心脏病学大会同步发表循证医学结果,证实植入Firehawk®/火鹰®支架低风险心肌梗死患者实际仅需1个月双抗疗程且出血并发症可大幅减少54%
(2025-09-05)《柳叶刀》:血压控低,利大于弊!中国科学家首次大规模评估强化血压控制风险获益比,较标准降压心血管事件风险降低24%,收益超过弊端
(2025-09-05)- (2025-09-05)
- (2025-09-05)
- (2025-09-05)
- (2025-09-04)
- (2025-09-04)
- (2025-09-04)
- (2025-09-04)
- (2025-09-04)
- (2025-09-04)
- (2025-09-04)
- (2025-09-04)
- (2025-09-04)
- (2025-09-04)
- (2025-09-04)
- (2025-09-04)
- (2025-09-04)
- (2025-09-03)
- (2025-09-03)
- (2025-09-03)
- (2025-09-03)
- (2025-09-03)
- (2025-09-03)
Nature Materials:程强/魏妥团队开发新型LNP,将mRNA精准送达肺/肝/脾/胸腺/骨骼,实现器官精准先导编辑
(2025-09-03)- (2025-09-03)
- (2025-09-02)
- (2025-09-02)
- (2025-09-02)
- (2025-09-02)
- (2025-09-02)
- (2025-09-02)
- (2025-09-02)
《JAMA·肿瘤学》:GLP-1受体激动剂抗癌,又迈一步!GLP-1RAs与肥胖/超重人群患癌风险降低相关,卵巢癌风险几近腰斩
(2025-09-02)- (2025-09-02)
- (2025-09-02)
- (2025-09-02)
- (2025-09-02)
- (2025-09-02)
- (2025-09-02)
- (2025-09-01)
- (2025-09-01)
- (2025-09-01)
- (2025-09-01)
- (2025-09-01)
- (2025-09-01)
- (2025-09-01)
全球首款 | 迈威生物靶向 IL-11 单抗创新药 9MW3811 针对病理性瘢痕的 II 期临床试验申请获 NMPA 受理
(2025-09-01)- (2025-09-01)
- (2025-09-01)
- (2025-09-01)
- (2025-09-01)
- (2025-09-01)
- (2025-09-01)
- (2025-09-01)
- (2025-09-01)